FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016381211> ?p ?o ?g. }

• W2016381211 endingPage "1780" @default.
• W2016381211 startingPage "1774" @default.
• W2016381211 abstract "INTRODUCTION AND OBJECTIVES Prostatic inflammation could be a key component in prostate enlargement and benign prostatic hyperplasia (BPH) progression. Our aim was to characterize inflammatory cells infiltrate within BPH tissue and to correlate inflammation and clinical data. MATERIAL AND METHODS Inflammation was profiled on three clinical outcome tissue microarrays (TMAs), including 282 patients treated by surgery for a complicated and/or symptomatic BPH. Inflammation score was defined by combining six cytological parameters and five markers on immunohistochemistry (IHC). Cytological parameters were lymphocytes, macrophages, and polynuclears leukocytes infiltrates, and three glandular aspect modifications: glandular atrophy, glandular destruction, and tissue fibrosis. IHC markers were CD3, CD4, and CD8 decorating T-lymphocytes, CD20 decorating B-lymphocytes, and CD163 decorating macrophages. RESULTS The majority of patients had inflammatory cells infiltrating BPH tissues: 81% had T-lymphocytes markers (CD3), 52% had B-lymphocytes markers (CD20), and 82% had macrophages markers (CD163). IPSS score (21 vs. 12; P = 0.02) and prostate volume (77 cm3 vs. 62 cm3; P = 0.002) were significantly higher in patients with high-grade prostatic inflammation. CONCLUSION We characterized inflammatory cells infiltrate in a large cohort of surgically treated BPH specimens. The role of inflammation in BPH development was highlighted by the strong correlation between histological inflammation, IPSS, and prostate volume. Prostate enlargement due to chronic inflammatory process may progressively conduce to BPH progression. Therefore, inflammation is a therapeutic target for BPH. Prostate 69: 1774–1780, 2009. © 2009 Wiley-Liss, Inc." @default.
• W2016381211 created "2016-06-24" @default.
• W2016381211 creator A5011214982 @default.
• W2016381211 creator A5027890396 @default.
• W2016381211 creator A5033163047 @default.
• W2016381211 creator A5039572663 @default.
• W2016381211 creator A5047666476 @default.
• W2016381211 creator A5061975059 @default.
• W2016381211 creator A5062172259 @default.
• W2016381211 creator A5089320369 @default.
• W2016381211 creator A5090538658 @default.
• W2016381211 date "2009-08-07" @default.
• W2016381211 modified "2023-10-12" @default.
• W2016381211 title "Inflammation in benign prostatic hyperplasia: A 282 patients' immunohistochemical analysis" @default.
• W2016381211 cites W1964621103 @default.
• W2016381211 cites W1977648249 @default.
• W2016381211 cites W1978472910 @default.
• W2016381211 cites W1986878226 @default.
• W2016381211 cites W1988222534 @default.
• W2016381211 cites W2027326367 @default.
• W2016381211 cites W2040112705 @default.
• W2016381211 cites W2052350551 @default.
• W2016381211 cites W2055663481 @default.
• W2016381211 cites W2058048513 @default.
• W2016381211 cites W2060516416 @default.
• W2016381211 cites W2065579733 @default.
• W2016381211 cites W2086584787 @default.
• W2016381211 cites W2144563350 @default.
• W2016381211 cites W2163525357 @default.
• W2016381211 cites W2791647845 @default.
• W2016381211 doi "https://doi.org/10.1002/pros.21027" @default.
• W2016381211 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2833181" @default.
• W2016381211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19670242" @default.
• W2016381211 hasPublicationYear "2009" @default.
• W2016381211 type Work @default.
• W2016381211 sameAs 2016381211 @default.
• W2016381211 citedByCount "217" @default.
• W2016381211 countsByYear W20163812112012 @default.
• W2016381211 countsByYear W20163812112013 @default.
• W2016381211 countsByYear W20163812112014 @default.
• W2016381211 countsByYear W20163812112015 @default.
• W2016381211 countsByYear W20163812112016 @default.
• W2016381211 countsByYear W20163812112017 @default.
• W2016381211 countsByYear W20163812112018 @default.
• W2016381211 countsByYear W20163812112019 @default.
• W2016381211 countsByYear W20163812112020 @default.
• W2016381211 countsByYear W20163812112021 @default.
• W2016381211 countsByYear W20163812112022 @default.
• W2016381211 countsByYear W20163812112023 @default.
• W2016381211 crossrefType "journal-article" @default.
• W2016381211 hasAuthorship W2016381211A5011214982 @default.
• W2016381211 hasAuthorship W2016381211A5027890396 @default.
• W2016381211 hasAuthorship W2016381211A5033163047 @default.
• W2016381211 hasAuthorship W2016381211A5039572663 @default.
• W2016381211 hasAuthorship W2016381211A5047666476 @default.
• W2016381211 hasAuthorship W2016381211A5061975059 @default.
• W2016381211 hasAuthorship W2016381211A5062172259 @default.
• W2016381211 hasAuthorship W2016381211A5089320369 @default.
• W2016381211 hasAuthorship W2016381211A5090538658 @default.
• W2016381211 hasBestOaLocation W20163812112 @default.
• W2016381211 hasConcept C114684123 @default.
• W2016381211 hasConcept C121608353 @default.
• W2016381211 hasConcept C126322002 @default.
• W2016381211 hasConcept C142724271 @default.
• W2016381211 hasConcept C167672396 @default.
• W2016381211 hasConcept C18031839 @default.
• W2016381211 hasConcept C193270364 @default.
• W2016381211 hasConcept C202751555 @default.
• W2016381211 hasConcept C203014093 @default.
• W2016381211 hasConcept C204232928 @default.
• W2016381211 hasConcept C2775858924 @default.
• W2016381211 hasConcept C2776235491 @default.
• W2016381211 hasConcept C2776460901 @default.
• W2016381211 hasConcept C2776914184 @default.
• W2016381211 hasConcept C2777562237 @default.
• W2016381211 hasConcept C2779244956 @default.
• W2016381211 hasConcept C2780192828 @default.
• W2016381211 hasConcept C2780559512 @default.
• W2016381211 hasConcept C2781172350 @default.
• W2016381211 hasConcept C2911124710 @default.
• W2016381211 hasConcept C55493867 @default.
• W2016381211 hasConcept C71924100 @default.
• W2016381211 hasConcept C86803240 @default.
• W2016381211 hasConcept C8891405 @default.
• W2016381211 hasConceptScore W2016381211C114684123 @default.
• W2016381211 hasConceptScore W2016381211C121608353 @default.
• W2016381211 hasConceptScore W2016381211C126322002 @default.
• W2016381211 hasConceptScore W2016381211C142724271 @default.
• W2016381211 hasConceptScore W2016381211C167672396 @default.
• W2016381211 hasConceptScore W2016381211C18031839 @default.
• W2016381211 hasConceptScore W2016381211C193270364 @default.
• W2016381211 hasConceptScore W2016381211C202751555 @default.
• W2016381211 hasConceptScore W2016381211C203014093 @default.
• W2016381211 hasConceptScore W2016381211C204232928 @default.
• W2016381211 hasConceptScore W2016381211C2775858924 @default.
• W2016381211 hasConceptScore W2016381211C2776235491 @default.
• W2016381211 hasConceptScore W2016381211C2776460901 @default.
• W2016381211 hasConceptScore W2016381211C2776914184 @default.

• next